Introduction {#Sec1_86}
============

Representants of the genus *Enterococcus* are part of the normal human gut microbiota, some animals, and birds. The *Enterococcus* out of the organism can survive in different temperature ranges, salinity, pH and resist some detergents as dodecyl-sodium sulfate and bile (Shepard and Gilmore [@CR30_86]). Phylogenetically the enterococci are divided into 7 clusters resulting finally in 33 species (Naser *et al.*[@CR21_86]; Köhler [@CR19_86]). In human infections, *E. faecalis* and *E. faecium* are the most prevailing species (\>90%). The first is the most commonly isolated, but recently *E. faecium* has exhibited an important increase as infectious agent (Treitman *et al.*[@CR31_86]). The enterococcal infection includes surgical wounds, endocarditis, hepatobiliary sepsis, urinary tract infections, bacteremias and neonatal sepsis among the most important (Poh *et al.*[@CR24_86]). The majority of the enterococcal infections are endogeneous, but the crossed infection occurs mainly in hospitalized patients (Cookson *et al*. [@CR7_86]). *Enterococcus* in USA is the fourth most common cause of nosocomial infection and the third of bacteremia (Biendenbach *et al.*[@CR3_86]). In Europe these infections are less and represent a 7.2% of the total Martínez-Odrizola *et al.* ([@CR20_86]).

Enterococcal strains resistant to different antibiotics are a great public health problem, especially in isolated strains from hospital-acquired infections (Hidron et al. [@CR16_86]). Several genetic studies have described the complex functions related to horizontal gene transfer in enterococcal strains, which partly explains their high antimicrobial resistance (Arthur *et al.*[@CR1_86]; Clewell *et al.*[@CR6_86]). Vancomycin was the antimicrobial agent most active against this bacterium, however, today in different parts of the world, isolated enterococcal strains are resistant to vancomycin (Ridwan et al. [@CR25_86]; Chang *et al.*[@CR5_86]).

Various factors determine the *E. faecalis* virulence*,* outstanding among those on the cellular surface, as the aggregation substance (Agg), the extracellular surface protein (Esp) and some that are excreted out of the bacterial cell as cytolysin and hyaluronidase, among others (Fisher and Phillips [@CR13_86]; Semedo *et al.*[@CR28_86]; Koch et al. [@CR18_86]). Additionally, the *Enterococcus* spp. synthesizes heterogeneous antibacterial peptides or bacteriocins, also called enterocins (Giraffa [@CR15_86]). These products may give these bacteria an additional ecological tool to persist in environments colonized by competing microorganisms in order to remove them and take over the ecological niche (Padilla et al. [@CR22_86]).

In recent years, *E. faecalis* has a greater ability to cause infections on different human epithelia (Fisher and Phillips [@CR13_86]). Thus, more studies are needed to provide new knowledge about this bacterial specie

Currently, there is considerable information regarding the antimicrobial susceptibility, presence of virulence genes and bacteriocins in *E. faecalis* strains isolated from clinical specimens and food. However, it would also be important to study if strains that come from water wells possess the properties mentioned and if it is possible to transmit these characteristics to the intestinal microbiota of people who drink this water.

Is important to remark that in some rural areas of central Chile, where there is no drinking water, people use well water for drinking and for various domestic purposes.

For a better understanding of the biology of *E. faecalis*, the objectives of this study were to detect genes for virulence and bacteriocins in addition to studying the antimicrobial susceptibility of 78 strains of *E. faecalis* isolated from water wells for human consumption.

Materials and methods {#Sec2_86}
=====================

Isolates and bacterial identification {#Sec3_86}
-------------------------------------

Were studied 128 water wells. In 78 of them were isolated 78 *E. faecalis* strains in the Maule Region in central Chile during the year 2010. From each well were taken 20 ml of water with a sterile bottle at a deep of about 5 cm. The samples were taken within 2 h to the microbiology laboratory of the University of Talca where they were processed immediately. The water samples were diluted 1:9 in sterile distilled water and 50 μl of this dilution was plated on Bile-esculin agar (Merck, Darmstadt, Germany) and incubated at 37°C for 24 h. The identification of the 78 bacterial isolates was carried out through conventional biochemical tests (Facklam and Collins [@CR12_86]).

Antibacterial susceptibility and determination of the minimum inhibitory concentration (MIC) {#Sec4_86}
--------------------------------------------------------------------------------------------

The antibacterial susceptibility test was performed through the diffusion in agar test (Bauer et al. [@CR2_86]). The antimicrobials analyzed were: ampicillin, tetracycline, ciprofloxacin, moxifloxacin, gentamicin, vancomycin, chloramphenicol y erythromycin (VALTEK, Santiago, Chile). For determination of MIC, the antimicrobial were prepared in accordance with the manufacturers' instructions (Sigma, St Louis, MO, USA) and in accordance with the recommended by EUCAST ([@CR11_86]). All the resolutions of the MICs were performed in duplicate. *E. faecalis* strain ATCC 29212 was included as control in assays with or without antimicrobials.

Genes amplification and conditions for the PCR {#Sec5_86}
----------------------------------------------

The total DNA of *E. faecalis* strains was used in the PCR reactions to detect the presence of virulence genes as cytolysin (*cylA)*, aggregation substance *(aggA*), antigen A *(efaA),* stimulating of pheromones expression (*eep*), gelatinase (*gelE*) and surface protein (*esp*). Additionally were amplified the genes for enterocins AS-48 (*as-48*), bacteriocin 31 *(bac31*), enterocins A, B and P (*entA, entB, entP*), enterocin L50 A/B *(entL50A/B*), enterolysin A (*enlA*) and enterocin 1071 (*ent1071*). Each PCR reaction contained 10 mM Tris--HCl buffer pH 8.3, 1.5 mM MgCl~2,~ 50 mM KCl, 200 μM of each deoxinucleotide (Omega, BioTek, Doraville, GA), 1 μM of oligonucleotide, 2U of *Taq* DNA polymerase and 15 ng of DNA template (Table [1](#Tab1){ref-type="table"}).Table 1**Oligonucleotide sequences used in this study and their products**Virulence genesOligonucleotide sequencesProduct size (bp)Reference*cylA*for5′-TGGATGATAGTGATAGGAAGT-3′517Eaton and Gasson [@CR32_86]rev5′-TCTACAGTAAATCTTTCGTCA-3′*aggA*for5′-AAGAAAAAGTAGACCAAC-3′1553Eaton and Gasson [@CR32_86]rev5′-AACGGCAAGACAAGTAAATA-3′*efaA*for5′-GACAGACCCTCACGAATA-3′705Eaton and Gasson [@CR32_86]rev5′-AGTTCATCATGCTGCTGTAGTA-3′*eep*for5′-GAGCGGGTATTTTAGTTCGT-3′937Bittencourt de Marques and Suzart [@CR4_86]rev5′-TACTCCAGCATTGGATGCT-3′*enlA*for5′-TTCTTCTTATTCTGTCAACGCAGC-3′960Bittencourt de Marques and Suzart [@CR4_86]rev5′-GACTGTGAAATACCTATTTGCAAGC-3′*esp*for5′-TTGCTAATGCTAGTCCACGACC-3′933Shankar *et al*. [@CR29_86]rev5′-GCGTCAACACTTGCATTGCCGAA-3′**Bacteriocin genes***as*-48for5′-GAGGAGGAGTATCATGGTTAAAG-3′340Sabia et al. [@CR27_86]rev5′-CATATTGTTAAATTACCAAGCAATAA-3′*bac*31for5′-GAAAAAGAAATTAGTTATTTGTG-3′202Sabia et al. [@CR27_86]rev5′-CTATCTAGGAGCCCAAGG-3*entA*for5′-ATGAAACATTTAAAAATTTTGTCTA-3′130Sabia et al. [@CR27_86]rev5′-TTAGCACTTCCCTGGAATTG-3′*entB*for5′-GAAAATGATCACAGAATGCCTA-3′160Du Toit *et al*. [@CR9_86]rev5′-GTTGCATTTAGAGTATACATTTG-3′*entP*for5′-GTTAGTTTGTGACAAATTTTGG-3′120Sabia et al. [@CR27_86]rev5′-GGTGTGGAAAAGCCGTTTC-3′*entL50* A/Bfor5′-TGGGAGAATCGCAAAATTAG-3′96Du Toit *et al*. [@CR9_86]rev5′-ATTGCCCATCCTTCTCCAAT-3′*ent1071*for5′-ATATTTAGGGGGACCGATAA-3′405Sabia et al. [@CR27_86]rev5′-TATACATTCTTCCACTTATTTTT-3′

The reactions conditions for each gene were the following:

For the amplification of the virulence genes *cylA, aggA, efaA, eep, gelE* and *esp,* the samples with the DNA templates were denatured at 94°C by 5 m. Subsequently, 30 cycles were performed: 45 s at 94°C, 1 m at 57°C and 1 m at 72°C for the gene *cylA;* 30 cycles of 45 s at 94°C, 1 m at 52°C and 1 m at 72°C for the *aggA* and *efaA* genes; 30 cycles of 45 s a 94°C, 1 m at 58°C and 1 m at 72°C for the *eep* gene; 30 cycles of 30 s at 94°C, 30 s at 56°C and 30 s 72°C for the *gelE* gene; 30 cycles of 45 s at 94°C, 1 m at 62°C and 1 m at 72°C for the *esp* gene*.* The amplification of all the virulence genes was concluded with a final extension of 72°C by 3 m.

The PCR were performed in a thermal DNA Engine (Bio-Rad, Hercules, CA). The negative controls (without DNA template) were included in each reaction set and all performed double. The amplification products were analyzed through electrophoresis in agarose gels at 1.5% stained with ethidium bromide and visualized under ultraviolet light. The size of each amplified product was confirmed by comparison with the molecular size marker 1Kb-Plus DNA ladder (New England Biolabs).

Statistical analysis {#Sec6_86}
--------------------

The correlation between the presence of virulence and bacteriocin genes with the antimicrobial susceptibility of the *E. faecalis* strains, was determined using the Test of χ2 of Test Exact of Fisher, as it corresponded. A p \< 0.05 value was considered statistically significant to indicate the association between both variables. The statistical package used was SPSS v.19.0.

Results {#Sec7_86}
=======

From 128 water wells were isoalted 78 *E. faecalis* strains and were identified by conventional biochemical test.

Virulence and bacteriocin PCR products {#Sec8_86}
--------------------------------------

In the Table [2](#Tab2){ref-type="table"} it was observed that the *entA* gene (64.1%) is the most frequently detected followed by the *entL50A/B* (37.5%) and the *enlA* (26.9%) gene respectively. The *ent P* (8.9%) gene was the less frequent. The gene *as-48* was not detected. In the Table [3](#Tab3){ref-type="table"}, it is observed that 11 of the total of the studied strains exhibit 6 virulence genes and 2 bacteriocin genes. The main genetic profile was observed in 18 *E. faecalis* strains*,* in which 4 different virulence genes and 2 bacteriocinogenic genes were detected. The less common profile corresponded to 5 strains that carried 3 virulence genes and 2 bacteriocinogenic genes. Eight genetic profiles were determined that include virulence and bacteriocin genes (A, B, C, D, E, F, G y H profiles).Table 2**Virulence and bacteriocin genes in 78*Enterococcus faecalis*strains isolated from water wells for human consumption**Virulence genesNº%*aggA*7393.5*cylA*6076.9*efaA*3747.4*eep*3139.7*esp*5570.5*gelE*2430.7Bacteriocin genes*entB*1316.6*ent 1071*810.2*ent P*78.9*entL50A/B*2937.5*enlA*2126.9*entA*5064.1*bac31*1114.1*as-48*00Table 3**Virulence and bacteriocin genetic profiles in 78*E. faecalis*strains isolated from water wells for human consumption**Genetic profilesStrains**Virulence genesBacteriocinsnº%**(A) \* *efaA, aggA, esp, gelE, cylA, eepentA, bac31*1114.1(B) *efaA, aggA, esp, gelE, cylAentA, entB*810.2(C) *efaA, aggA, esp, gelEentA*, *entL50A/B*1823.0(D) *aggA, esp, cylA, eepenlA, entP*78.9(E) *aggA, esp, cylAentL50A/B, enlA*1114.1(F) *cylA, gelE, eepentA, entB*56.4(G) *cylA, eep, aggAentA, ent 1071*810.4(H) *cylA, aggA, gelEentA, enlA*1012.8Total78100\*: Name of genetic profile.

Antimicrobial susceptibility {#Sec9_86}
----------------------------

The Table [4](#Tab4){ref-type="table"} shows the resistance phenotypes (MICs) of the 78 *E*. *faecalis* strains. It is observed that 3 phenotypes exhibit resistance to 4 antibiotics simultaneously and 3 phenotypes show resistance to only one. In the same table, it is observed that the most common resistance phenotype (n = 14) corresponds to a tetracycline and chloramphenicol and the less frequent (n = 2) to ciprofloxacin and moxifloxacin. It was not observed resistance to vancomycin in any of the strains evaluated.Table 4**MICs of several antimicrobials against different resistance phenotypes of*E. faecalis*isolated from wells of water for human consumption**Median MIC (range) (mg/L)**Resistance phenotypeNumbers of strainsTAVCMChGE**T A Ch G864 (16--256)16 (4--128)64 (32--256)16 (8--128)G A Ch E1016 (8--64)64 (32--128)32 (16--64)16 (8--64)T A Ch E732 (8--128)8 (8--64)16 (8--128)16 (8--64)T G A1164 (16--128)8 (8--64)32 (16--128)T Ch1464 (16--256)64 (32--256)A G616 (8--128)32 (16--256)T C432 (8--128)8 (4--32)C M28 (4--32)16 (32--128)Ch564 (32--256)T664 (16--128)G532 (16--256)Total78T: tetracycline; A: ampicillin; V: vancomycin ; C: ciprofloxacin; M: moxifloxacin; Ch: chloramphenicol; G: gentamicin; E: erythromicin.

Relation between antimicrobial susceptibility and genetic profiles {#Sec10_86}
------------------------------------------------------------------

In accordance to statistical analysis it was observed a significant association between the resistance to tetracycline and chloramphenicol with the genetic profiles A, B, C, D and F and of sensitivity in presence of the genetic profiles E and H. It was observed that ampicillin resistance is associated to the genetic profiles A, B, C y D and of sensitivity with E and F (p \< 0.0001). The genetic profiles associated with the resistance to gentamicin were A, B, D and F and of sensitivity C and E (p \< 0.0001). Erythromicin, ciprofloxacin, moxifloxacin and vancomycin did not exhibit a significant statistically susceptibility association with the genetic profiles detected.

In the Table [5](#Tab5){ref-type="table"}, it is observed that the *E. faecalis* strains that exhibit a greater number of virulence and bacteriocin genes were more resistant to the antimicrobial. The greatest number of resistant strains was associated with tetracycline followed by chloramphenicol, ampicillin and gentamicin respectively. The lowest resistance of the strains was observed for moxifloxacin and ciprofloxacin.Table 5**Relation of virulence and bacteriocin genetic profiles and their respective antimicrobial resistance in*E. faecalis*strains isolated from water wells for human consumption**Virulence and bacteriocinNº of resistant strains and antimicrobials genetic profilesTAVCMChGE*efaA, aggA, esp, gelE, cylA, eepentA, bac31*1190211183*efaA, aggA, esp, gelE, cylAentA, entB*68010884*efaA, aggA, esp, gelEentA*, *entL50A/B*12110111133*aggA, esp, cylA, eepenlA, entP*54000572*aggA, esp, cylAentL50A/B, enlA*33000041*cylA, gelE, eepentA, entB*31000341*cylA, eep, aggAentA, ent 1071*42000420*cylA, aggA, gelEentA, enlA*52000233Total4940042443917T: tetracycline; A: ampicillin; V: vancomycin ; C: ciprofloxacin; M: moxifloxacin; Ch: chloramphenicol; G: gentamicin; E: erythromicin.

Discussion {#Sec11_86}
==========

*Enterococcus faecalis* is a very important bacterial specie as a pathogen acquired in hospitals of USA and Europe, especially in intensive care units, where are one of the main causes of bacteremia (Rodríguez-Baño *et al.*[@CR26_86]). Although there are various surveys addressed to know the causes because these microorganisms induce human infections, diverse aspects of its biology have not been revealed (Fisher and Phillips [@CR13_86]).

The results demonstrated that the majority of the bacterial strains had genes that codify for different virulence factors. The results of this study are coherent with the described in other studies (Koch *et al.*[@CR18_86]; Dupont *et al*. [@CR10_86]). The enterocin genes analyzed in this work represent the most frequently described in this bacterial specie (Franz *et al.*[@CR14_86]). The bateriocinogenic activity of *E. faecalis* is widely recognized and its bacteriocins have been object of interesting biotechnological studies associated to the biopreservation of foods (Khan *et al*. [@CR17_86]; Poeta *et al.*[@CR23_86]). The bacteriocinogenic capacity of these microorganisms grants an ecological superiority with respect to those strains that do not produce these antibacterial peptides. This property also grants survival advantages to the bacteriocinogenic strains, because these products are able to eliminate to potential competing microorganisms and start subsequently the colonization phase. It was very interesting to observe that all the studied strains exhibited two different types of genes for bacteriocins, which added to its respective virulence genes grant to these strains a greater pathogenic potentiality. Thus, bacteriocinogenic strains have an additional ecological tool to persist in environments colonized by competing microorganisms. Probably once introduced in the organism with the water these strains can more easily colonize; on the contrary they do not have an ecological benefit in aquatic environment where virulence factors and bacteriocins are diluted.

It was shown in this finding that most of the strains exhibit resistance to two or more antimicrobials. Specifically 25 strains present resistance to four different types of the antimicrobials used. This important resistance associated to high MICs confirms the recognized antimicrobial property of *E. faecalis* which is maintained in the studied strains. Also, in accordance to statistical analysis it is possible to argue that genetic profiles A, B, and D of *E. faecalis* are more frequently associated to resistance against some antimicrobials and inversely, the profiles C and E are associated with sensitivity.

The evolution and ecology of *E. faecalis*, is a subject of great importance and that must be constantly monitored to have new information to allow to know the biology of this bacterial specie. The results of this study demonstrate that intensive use of water wells for human consumption includes poor sanitary practices. This is the cause of bacterial contamination of the wells with human microbiota. This could explain the presence of *E. faecalis* in these wells. Although, generally contamination of the wells is due to environmental contamination of groundwater by fecal pollution, it is possible to consider that *E. faecalis* strains analyzed are circulating among the wells and the people who use this water resource. The observed properties in the studied bacterial strains are similar to those found in strains isolated from clinical samples. On the other hand, these strains are a serious problem for people who drink this water contaminated with *E. faecalis*, considering that these bacteria could transfer genetic information from antimicrobial resistance to their intestinal microbiota (De Niederhäusern *et al*. [@CR8_86]).

**Competing interest**

The authors declare that they have no competing interest.

**Authors' contributions**

CP: carried out part of the bacterial identification; carried out part of the molecular genetic studies; to made part of the writing and design of the manuscript; carried out the statistical analysis OL: carried out part of the bacterial identification; carried out part of the molecular genetic studies; to made part of the writing and design of the manuscript; carried out the statistical analysis The authors declare: All authors read and approved the final manuscript.
